Anti-Cancer Drugs Publishes Preclinical Data Demonstrating

Misetionamide showed broad antineoplastic activity in 15 different cancer types including multiple human cancer cell lines with no detrimental effect on...

Related Keywords

Switzerland ,Swiss ,Greg Bosch ,Sara Krane ,Lisa Descenza ,Linkedin ,Panavance Therapeutics Inc ,Head Nonclinical Research ,Anti Cancer Drugs ,Duane Sofia ,Cancer Drugs ,Investor Relations Contact ,Preclinical Data ,Ntineoplastic Activity ,R Duane Sofia ,Cancer Cell ,